Malignant Hypertension: Current Perspectives and Challenges
Open Access
- 5 April 2022
- journal article
- editorial
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (7) , e023397
Abstract
Malignant hypertension is a hypertensive emergency, with rapid disease progression and poor prognosis. Although recognized as a separate entity more than a century ago, significant knowledge gaps remain about its pathogenesis and treatment. This narrative review summarizes current viewpoints, research gaps, and challenges with a view to pooling future efforts at improving treatment and prognosis.Keywords
This publication has 20 references indexed in Scilit:
- HypertensionJournal Of Hypertension, 2018
- Malignant Hypertension Revisited—Does This Still Exist?American Journal of Hypertension, 2017
- From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergencyJournal of Human Hypertension, 2015
- Mortality and Cardiovascular Risk in Patients With a History of Malignant Hypertension: A Case‐Control StudyThe Journal of Clinical Hypertension, 2013
- Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: The Studying the Treatment of Acute hyperTension (STAT) RegistryAmerican Heart Journal, 2009
- The Renin-Angiotensin System in Malignant Hypertension Revisited: Plasma Renin Activity, Microangiopathic Hemolysis, and Renal Failure in Malignant HypertensionAmerican Journal of Hypertension, 2007
- Hypertensive and renal effects of chronic low level intrarenal angiotensin infusion in the dog.Circulation Research, 1979
- Malignant HypertensionArchives of internal medicine (1960), 1974
- Malignant hypertension. Current modes of therapyArchives of internal medicine (1960), 1974
- Classification of hypertension and clinical differentiation of the malignant typeAmerican Heart Journal, 1927